Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
42,833,193
-
Total 13F shares
-
43,453,740
-
Share change
-
+5,096
-
Total reported value
-
$7,794,694,945
-
Put/Call ratio
-
53%
-
Price per share
-
$179.41
-
Number of holders
-
397
-
Value change
-
+$9,014,738
-
Number of buys
-
165
-
Number of sells
-
193
Institutional Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q2 2021
As of 30 Jun 2021,
UNITED THERAPEUTICS Corp - Common Stock (UTHR) was held by
397 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
43,453,740 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Avoro Capital Advisors LLC, FMR LLC, STATE STREET CORP, ACADIAN ASSET MANAGEMENT LLC, Bank of New York Mellon Corp, GEODE CAPITAL MANAGEMENT, LLC, and Palo Alto Investors LP.
This page lists
397
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.